Regarding psychiatric disorders, the latest pathway-based genome-wide association studies by the Psychiatric Genomic Consortium46 found that methylation pathways, inclusive of the SAM-dependent methyltransferase activity, are among the most important in the common background of major depression, bipolar depression and schizophrenia. The gene discussed is THUMPD2; the disease is schizophrenia.